Global Summit on Immunotherapy & Cancer Breakthroughs (GSICB 2026)
31st December 2026 – 1st January 2027 · Bordeaux, France
- Dates
- 31st December 2026 – 1st January 2027
- Format
- In person
- Paper deadline
- 4th December 2026 (39 days left)
- Type
- Conference
Verification and trust
- Organizer account: not a verified organizer account; listed from a public submission.
- Official website: listed; registration and submission details are on the organizer's site.
- Venue, fees and speakers: as published by the organizer; not independently checked.
Before you pay, read our Verification Standards. ·
About GSICB 2026
Global Summit on Immunotherapy & Cancer Breakthroughs GSICB, organized by World Research Association for Education and Science, is a leading international conference that connects researchers, engineers, healthcare professionals, academicians, scientists, industry experts, and professionals from around the world. The conference provides a global platform to share groundbreaking research, discuss emerging developments, showcase innovative ideas, and build meaningful professional collaborations. By bringing together diverse academic and professional communities, Global Summit on Immunotherapy & Cancer Breakthroughs GSICB aims to promote knowledge exchange, interdisciplinary collaboration, innovation, and the advancement of research on a global scale.
Description provided by the organizer.
Call for papers: tracks
- Advanced Cancer Immunotherapy
- • Next Generation Immunotherapy
- • Precision Cancer Immunotherapy
- • Immune Checkpoint Inhibitors
- • PD1 PDL1 Targeting
- • CTLA4 Targeted Therapy
- • Nextgen Checkpoint Strategies
- • CAR T Cell Therapy
- • Next Generation CAR T
- • In Vivo CAR T
- • CAR NK Cell Therapy
- • Engineered T Cell Therapies
- • TCR T Cell Therapy
- • Adoptive Cell Therapies
- • Tumor Infiltrating Lymphocytes
- • Bispecific Antibody Therapies
- • Multispecific Immune Engagers
- • T Cell Engager Platforms
- • Cancer Vaccine Innovations
- • Personalized Cancer Vaccines
- • Neoantigen Vaccine Development
- • mRNA Cancer Vaccines
- • In Situ Cancer Vaccines
- • Oncolytic Virus Immunotherapy
- • Cancer Immunotherapy Combinations
- • Immunotherapy Drug Combinations
- • Targeted Immunotherapy Strategies
- • Tumor Microenvironment Modulation
- • Immune Suppressive Microenvironment
- • Tumor Immune Escape
- • Immunotherapy Resistance Mechanisms
- • Overcoming Immunotherapy Resistance
- • Biomarkers For Immunotherapy
- • Predictive Immune Biomarkers
- • Precision Immuno Oncology
- • AI Driven Immunotherapy
- • Computational Cancer Immunology
- • Genomic Immunotherapy Biomarkers
- • Personalized Immune Treatments
- • Immunotherapy For Solid Tumors
- • Immunotherapy For Blood Cancers
- • Lung Cancer Immunotherapy
- • Breast Cancer Immunotherapy
- • Melanoma Immunotherapy Advances
- • Colorectal Cancer Immunotherapy
- • Brain Cancer Immunotherapy
- • Immunotherapy Toxicity Management
- • Cytokine Release Syndrome
- • Immune Related Adverse Events
- • Clinical Immunotherapy Translation
Important dates
| Paper submission deadline | 4th December 2026 |
| Conference | 31st December 2026 – 1st January 2027 |
Venue and travel
Bordeaux
Bordeaux, France
Frequently asked questions about GSICB 2026
When and where is GSICB 2026?
GSICB 2026 takes place 31st December 2026 – 1st January 2027 in Bordeaux, France.
Is GSICB 2026 in-person or virtual?
GSICB 2026 is listed as an in-person event in Bordeaux. Check the official website for any online participation option.
What is the paper submission deadline for GSICB 2026?
The listed paper submission deadline is 4th December 2026. Confirm the current deadline on the official website before submitting.
Who organizes GSICB 2026?
Registration and submission details are on the official conference website.
Figures updated 26th October 2026.